ApoB-containing lipoproteins promote infectivity of chlamydial species in human hepatoma cell line

World Journal of Hepatology

Volumn 2, Issue 2, 2010, Pages 74-80

  Bashmakov, Yuriy K ^a   Zigangirova, Nailia A ^b   Gintzburg, Alexander L ^b   Bortsov, Petr A ^b   Petyaev, Ivan M ^a  

^a Cambridge Theranostics Ltd   (United Kingdom)

^b GAMALEYA RESEARCH INSTITUTE OF EPIDEMIOLOGY AND MICROBIOLOGY   (Russian Federation)

Author keywords

ApoB containing lipoproteins; Chlamydial pneumoniae; Chlamydial trachomatis; Human hepatoma cell line; Liver infection

Indexed keywords

EID: 84869017370     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v2.i2.74     Document Type: Article

References (20)

1. von Haehling S, Schefold JC, Springer J, Anker SD. The cholesterol paradox revisited: heart failure, systemic inflammation, and beyond. Heart Fail Clin 2008; 4: 141-151
2. Murch O, Collin M, Hinds CJ , Thiemermann C. Lipoproteins in inflammation and sepsis. I. Basic science. Intensive Care Med 2007; 33: 13-24
3. Berbee JF, van der Hoogt CC, Kleemann R, Schippers EF, Kitchens RL, van Dissel JT, Bakker-Woudenberg IA, Havekes LM, Rensen PC. Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis. FASEB J 2006; 20: 2162-2164
4. Ma J, Liao XL, Lou B, Wu MP. Role of apolipoprotein A-I in protecting against endotoxin toxicity. Acta Biochim Biophys Sin (Shanghai) 2004; 36: 419-424
5. Cai L, Ji A, de Beer FC, Tannock LR, van der Westhuyzen DR. SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest 2008; 118: 364-375
6. André P, Perlemuter G, Budkowska A, Bréchot C, Lotteau V. Hepatitis C virus particles and lipoprotein metabolism. Semin Liver Dis 2005; 25: 93-104
7. Wunschmann S, Muller HM, Stipp CS, Hemler ME, Stapleton JT. In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs. J Infect Dis 2006; 194: 1058-1067
8. Cao F, Castrillo A, Tontonoz P, Re F, Byrne GI. Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect Immun 2007; 75: 753-759
9. Garber DW, Kulkarni KR, Anantharamaiah GM. A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples. J Lipid Res 2000; 41: 1020-1026
10. Gallou-Kabani C, Vigé A, Gross MS, Boileau C, Rabes JP, Fruchart-Najib J, Jais JP, Junien C. Resistance to high-fat diet in the female progeny of obese mice fed a control diet during the periconceptual, gestation, and lactation periods. Am J Physiol Endocrinol Metab 2007; 292: E1095-E1100
11. Rashid S, Curtis DE, Garuti R, Anderson NN, Bashmakov Y, Ho YK, Hammer RE, Moon YA, Horton JD. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Proc Natl Acad Sci USA 2005; 102: 5374-5379
12. Kutlin AV, Drobyshevskaia EI, Shatkin AA. [The immunochemical and biological properties of monoclonal antibodies to Chlamydia trachomatis] Zh Mikrobiol Epidemiol Immunobiol 1996; 3-6
13. Caldwell HD, Kromhout J, Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981; 31: 1161-1176
14. Diaz O, Delers F, Maynard M, Demignot S, Zoulim F, Chambaz J, Trépo C, Lotteau V, André P. Preferential association of Hepatitis C virus with apolipoprotein B48- containing lipoproteins. J Gen Virol 2006; 87: 2983-2991
15. Dessus-Babus S, Belloc F, Bébéar CM, Poutiers F, Lacombe F, Bébéar C, de Barbeyrac B. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry. Cytometry 1998; 31: 37-44
16. Wang G, Burczynski F, Anderson J, Zhong G. Effect of host fatty acid-binding protein and fatty acid uptake on growth of Chlamydia trachomatis L2. Microbiology 2007; 153: 1935-1939
17. Puolakkainen M, Kuo CC, Campbell LA. Chlamydia pneumoniae uses the mannose 6-phosphate/insulin-like growth factor 2 receptor for infection of endothelial cells. Infect Immun 2005; 73: 4620-4625
18. Jutras I, Abrami L, Dautry-Varsat A. Entry of the lymphogranuloma venereum strain of Chlamydia trachomatis into host cells involves cholesterol-rich membrane domains. Infect Immun 2003; 71: 260-266
19. Dautry-Varsat A, Balañá ME, Wyplosz B. Chlamydia--host cell interactions: recent advances on bacterial entry and intracellular development. Traffic 2004; 5: 561-570
20. Moore KJ, Freeman MW. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 2006; 26: 1702-1711